Log in
In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

EBR:GBLB - Groep Brussel Lambert Stock Price, Forecast & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume157,115 shs
Average Volume162,444 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Groupe Bruxelles Lambert SA invests in a portfolio of industrial and services companies operating in various sectors. The company operates through three segments: Holding, Imerys, and Sienna Capital. It operates in Belgium, other European countries, North America, and internationally. The company was founded in 1902 and is based in Brussels, Belgium. Read More…

Industry, Sector and Symbol

Industry Asset Management



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive GBLB News and Ratings via Email

Sign-up to receive the latest news and ratings for GBLB and its competitors with MarketBeat's FREE daily newsletter.


If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

Groep Brussel Lambert (EBR:GBLB) Frequently Asked Questions

What is Groep Brussel Lambert's stock symbol?

Groep Brussel Lambert trades on the EBR under the ticker symbol "GBLB."

Has Groep Brussel Lambert been receiving favorable news coverage?

News coverage about GBLB stock has trended very negative this week, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Groep Brussel Lambert earned a daily sentiment score of -3.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Groep Brussel Lambert.

Who are some of Groep Brussel Lambert's key competitors?

What other stocks do shareholders of Groep Brussel Lambert own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Groep Brussel Lambert investors own include Freeport-McMoRan (FCX), Glencore (GLEN), Nestlé (NESN), Ion Geophysical (IO), General Electric (GE), BP (BP), Cofinimmo NV/SA (COFB), Chevron (CVX), Starbucks (SBUX) and Vodafone Group (VOD).

Who are Groep Brussel Lambert's key executives?

Groep Brussel Lambert's management team includes the folowing people:
  • Mr. Ian Gallienne, Co-CEO, MD & Director (Age 48)
  • Mr. Gérard Lamarche, Co-CEO, MD & Director (Age 58)
  • Mr. Xavier Likin CPA, Chief Financial Officer (Age 51)
  • Mr. Colin Hall, Head of Investments (Age 49)
  • Sophie Gallaire, Head of Investor Relations

What is Groep Brussel Lambert's official website?

The official website for Groep Brussel Lambert is http://www.gbl.be/.

How can I contact Groep Brussel Lambert?

Groep Brussel Lambert's mailing address is Avenue Marnix 24, BRUXELLES, 1000, Belgium. The company can be reached via phone at +32-2-2891717.

MarketBeat Community Rating for Groep Brussel Lambert (EBR GBLB)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  198
MarketBeat's community ratings are surveys of what our community members think about Groep Brussel Lambert and other stocks. Vote "Outperform" if you believe GBLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GBLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Featured Article: Inverted Yield Curve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel